We are proud to welcome CatSci Ltd amongst our customers and collaborators. CatSci is a scientifically-led, commercially-mined and award-winning innovation partner for medicines development dedicated to developing economically and environmentally sustainable pharmaceutical manufacturing processes.
Dr Nigel Richardson, the Director of Analytical Technology and New Modalities at CatSci said: “We are delighted to be partnering with Shimadzu to build the new CatSci analytical laboratory at LondonEast, Dagenham, UK.” CatSci is expanding its capabilities in material science, analytical science and preformulation studies to better serve its customers’ needs. This expansion will be supported by a $4.2 m investment over the next two years and the opening of a secondary site in Dagenham, in April 2021. The company’s enhanced capabilities will include addressing additional modalities and asset classes, such as oligonucleotides, alongside additional capacity for GMP analytical testing.
This exciting collaboration shall promote ground-breaking scientific analysis and further advances in the pharmaceutical industry. Dr Richardson agreed, stating “Through this collaboration we will power the delivery of tailored analytical solutions to our customers with access to state-of-art equipment and engineering. Together with Shimadzu, we aim to set a new exemplary standard for measurement science to expedite medicines development’’.
To find out more about CatSci visit www.catsci.com